Texas judge rules Allergan ’s Restasis patents invalid

U.S. judge William Bryson ruled that patents covering Allergan‘s (NYSE:AGN) Restasis medicine are invalid on the grounds of obviousness, driving the company’s shares down more than -6% in afternoon trading today. The decision, made in a Texas federal court, is part of an ongoing case between Allergan and generic drugmakers like Mylan (NSDQ:MYL) and Teva Pharmaceuticals (NYSE:TEVA). Get the full story at our sister site, Drug Delivery Business News. The post Texas judge rules Allergan’s Restasis patents invalid appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Legal News Optical/Ophthalmic Patent Infringement Pharmaceuticals Wall Street Beat Allergan Inc. Mylan Teva Pharmaceuticals Source Type: news